Deferasirox-induced renal impairment in children: an increasing concern for pediatricians
Pediatric Nephrology, 04/30/2012Dubourg L et al.
Renal toxicity is a frequent adverse event of Deferasirox treatment, presenting as both glomerular and proximal dysfunction. A routine renal assessment is therefore required to prevent chronic kidney disease that may result from prolonged tubular injury.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.